Review

Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection

Published online:

Abstract

Co-infection with Mycobacterium tuberculosis is the leading cause of death in individuals infected with HIV-1. It has long been known that HIV-1 infection alters the course of M. tuberculosis infection and substantially increases the risk of active tuberculosis (TB). It has also become clear that TB increases levels of HIV-1 replication, propagation and genetic diversity. Therefore, co-infection provides reciprocal advantages to both pathogens. In this Review, we describe the epidemiological associations between the two pathogens, selected interactions of each pathogen with the host and our current understanding of how they affect the pathogenesis of TB and HIV-1/AIDS in individuals with co-infections. We evaluate the mechanisms and consequences of HIV-1 depletion of T cells on immune responses to M. tuberculosis. We also discuss the effect of HIV-1 infection on the control of M. tuberculosis by macrophages through phagocytosis, autophagy and cell death, and we propose models by which dysregulated inflammatory responses drive the pathogenesis of TB and HIV-1/AIDS.

  • Subscribe to Nature Reviews Microbiology for full access:

    $59

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    et al. Timing the ancestor of the HIV-1 pandemic strains. Science 288, 1789–1796 (2000).

  2. 2.

    Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5, 39–47 (2007).

  3. 3.

    The Joint United Nations Programme on HIV/AIDS. Global AIDS update 2016 (UNAIDS, 2016).

  4. 4.

    World Health Organisation. Global tuberculosis report 2016 (WHO, 2016).

  5. 5.

    et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 388, 1089–1102 (2016).

  6. 6.

    et al. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am. J. Respir. Crit. Care Med. 159, 94–99 (1999).

  7. 7.

    , , & Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS ONE 9, e82235 (2014).

  8. 8.

    , , & Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS 29, 1987–2002 (2015). This study presents a meta-analysis including >3,200 autopsies from low-income and middle-income countries, which estimated that TB was the cause of death in 37.2% of individuals infected with HIV-1.

  9. 9.

    et al. How soon after infection with HIVdoes the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J. Infect. Dis. 191, 150–158 (2005).

  10. 10.

    , , & HIV infection-associated tuberculosis: the epidemiology and the response. Clin. Infect. Dis. 50 (Suppl. 3), S201–S207 (2010).

  11. 11.

    , , & Pulmonary tuberculosis: radiological features in west Africans coinfected with HIV. Br. J. Radiol. 72, 339–344 (1999).

  12. 12.

    , , , & Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung 191, 27–34 (2013).

  13. 13.

    et al. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS 4, 981–985 (1990).

  14. 14.

    et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157, 1271–1278 (1996).

  15. 15.

    , , , & Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis. AIDS 30, 395–404 (2016).

  16. 16.

    et al. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J. Virol. 76, 1697–1706 (2002).

  17. 17.

    et al. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. J. Infect. Dis. 184, 1127–1133 (2001).

  18. 18.

    et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am. J. Respir. Crit. Care Med. 155, 996–1003 (1997).

  19. 19.

    et al. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects. J. Infect. Dis. 207, 1841–1849 (2013).

  20. 20.

    et al. Immune activation at sites of HIV/TB co-infection contributes to the pathogenesis of HIV-1 disease. PLoS ONE 11, e0166954 (2016).

  21. 21.

    , , , & Latent and active tuberculosis infection increase immune activation in individuals co-infected with HIV. EBioMedicine 2, 334–340 (2015).

  22. 22.

    et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126, 946–954 (1997).

  23. 23.

    et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104, 942–947 (2004).

  24. 24.

    et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151, 129–135 (1995).

  25. 25.

    , , , & Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int. J. Tuberc. Lung Dis. 5, 225–232 (2001).

  26. 26.

    et al. Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania. Tuberculosis 93, 461–466 (2013).

  27. 27.

    et al. In search of a new paradigm for protective immunity to TB. Nat. Rev. Microbiol. 12, 289–299 (2014).

  28. 28.

    et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13, 223–228 (2012).

  29. 29.

    et al. Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity 41, 493–502 (2014).

  30. 30.

    et al. A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages. EMBO J. 36, 604–616 (2017). HIV-1 is able to productively infect macrophages in non-replicative cell cycles during which SAMHD1 is inactivated, providing a niche that HIV-1 has exploited without a countermeasure for SAMHD1 restriction.

  31. 31.

    et al. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol. 7, 1116–1126 (2014). This study identifies direct evidence for productive HIV-1 infection in up to 5% of alveolar macrophages in bronchoalveolar lavage specimens by RNA fluorescence in situ hybridization, and further assessments using reporter beads show that these cells exhibit impaired phagocytosis.

  32. 32.

    et al. Macrophages sustain HIV replication in vivo independently of T cells. J. Clin. Invest. 126, 1353–1366 (2016). HIV-1 is able to sustain long-term productive infection in vivo in a mouse model with human myeloid cells, but without T cells, indicating that macrophages are sufficient to support chronic HIV-1 infection.

  33. 33.

    et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl Acad. Sci. USA 98, 658–663 (2001).

  34. 34.

    , , , & Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages. AIDS Res. Hum. Retroviruses 31, 64–70 (2015).

  35. 35.

    et al. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Nat. Med. 23, 638–643 (2017).

  36. 36.

    , , , & HIV reservoirs: what, where and how to target them. Nat. Rev. Microbiol. 14, 55–60 (2016).

  37. 37.

    et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530, 51–56 (2016).

  38. 38.

    et al. Multiple origins of virus persistence during natural control of HIV infection. Cell 166, 1004–1015 (2016).

  39. 39.

    et al. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J. Neurovirol. 12, 146–152 (2006).

  40. 40.

    , , , & Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87–103 (2015).

  41. 41.

    et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83, 3719–3733 (2009).

  42. 42.

    et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor–viral RNA interactions. J. Clin. Invest. 115, 3265–3275 (2005).

  43. 43.

    et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS ONE 7, e29291 (2012).

  44. 44.

    et al. HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3. Nat. Immunol. 18, 225–235 (2017).

  45. 45.

    et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903–906 (2013).

  46. 46.

    et al. PQBP1 is a proximal sensor of the cGAS-dependent innate response to HIV-1. Cell 161, 1293–1305 (2015).

  47. 47.

    et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc. Natl Acad. Sci. USA 110, E4571–E4580 (2013).

  48. 48.

    et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601–605 (2014).

  49. 49.

    , & HIV-1 and interferons: who's interfering with whom? Nat. Rev. Microbiol. 13, 403–413 (2015).

  50. 50.

    et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503, 402–405 (2013).

  51. 51.

    et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 23, 2255–2263 (2009).

  52. 52.

    , & Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 60, 471–484 (2009).

  53. 53.

    et al. Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection. Sci. Transl Med. 8, 358ra125 (2016).

  54. 54.

    et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112, 2826–2835 (2008).

  55. 55.

    et al. Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques. Cell Host Microbe 19, 529–540 (2016).

  56. 56.

    et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509–514 (2013).

  57. 57.

    et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343, 428–432 (2014).

  58. 58.

    et al. Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells. Cell Rep. 12, 1555–1563 (2015).

  59. 59.

    & Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe 19, 280–291 (2016).

  60. 60.

    et al. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 498, 376–379 (2013).

  61. 61.

    HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 62, 141–155 (2011).

  62. 62.

    & Revisiting immune exhaustion during HIV infection. Curr. HIV/AIDS Rep. 8, 4–11 (2011).

  63. 63.

    et al. Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection. Nat. Immunol. 17, 593–603 (2016). Evidence from patients infected with HIV-1 and the chronic LCMV mouse infection model indicates that persistently elevated TNF levels can inhibit T helper cell function by upregulating expression of inhibitory molecules such as PD1, suggesting a mechanism by which chronic inflammation can lead to immunodeficiency.

  64. 64.

    , , & HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199, 283–293 (2004).

  65. 65.

    Cell-to-cell transmission of retroviruses: innate immunity and interferon-induced restriction factors. Virology 411, 251–259 (2011).

  66. 66.

    et al. HIV cell-to-cell spread results in earlier onset of viral gene expression by multiple infections per cell. PLoS Pathog. 12, e1005964 (2016).

  67. 67.

    et al. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe 16, 711–721 (2014).

  68. 68.

    et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages. J. Exp. Med. 198, 693–704 (2003). Transcriptional profiling of M. tuberculosis isolated from phagosomes compared with bacteria grown in broth culture reveals that in response to phagosomal uptake and the effects of host IFNγ or inducible nitric oxide synthase, the bacteria upregulate iron scavenging systems, expression of dormancy-related genes and genes that support anaerobic respiration.

  69. 69.

    , & Mycobacterial dormancy systems and host responses in tuberculosis. Front. Immunol. 8, 84 (2017).

  70. 70.

    et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog. 8, e1002507 (2012).

  71. 71.

    et al. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327, 466–469 (2010).

  72. 72.

    et al. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 12, 1046–1063 (2010).

  73. 73.

    & The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37–49 (2009).

  74. 74.

    , , , & Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011, 405310 (2011).

  75. 75.

    et al. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe 17, 811–819 (2015).

  76. 76.

    et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770–1773 (2006).

  77. 77.

    et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010).

  78. 78.

    et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99–103 (2014).

  79. 79.

    , , & Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 11, 469–480 (2012).

  80. 80.

    et al. Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe 17, 799–810 (2015). Inflammasome activation leading to secretion of active IL-1β and induction of type 1 interferons by macrophages infected with M. tuberculosis is dependent on the mycobacterial ESX-1 secretion system, and specific targeting of EsxA secretion attenuated induction of interferons but not activation of the inflammasome.

  81. 81.

    et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J. Clin. Invest. 121, 1827–1833 (2011).

  82. 82.

    et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42, 498–503 (2010).

  83. 83.

    et al. M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens. Cell Host Microbe 18, 538–548 (2015).

  84. 84.

    & The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J. Allergy Clin. Immunol. 122, 1043–1053 (2008).

  85. 85.

    et al. In Vivo molecular dissection of the effects of HIV-1 in active tuberculosis. PLoS Pathog. 12, e1005469 (2016). Genome-wide transcriptional profiling of biopsy samples from the site of the TST to make molecular-level and systems-level assessments of human immune responses to a standardized mycobacterial challenge reveals deficient IL-10 responses in patients infected with HIV-1 before severe immunodeficiency, preserved type 1 interferon responses in patients infected with HIV-1 with severe immunodeficiency and exaggerated TH2 cell responses during unmasking TB-IRIS after ART.

  86. 86.

    et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am. J. Respir. Crit. Care Med. 180, 1262–1270 (2009).

  87. 87.

    et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J. Exp. Med. 207, 2869–2881 (2010). Preferential depletion of M. tuberculosis-reactive CD4+ T cells, which produced more IL-2 and were more permissive to HIV-1 infection, suggests that HIV-1 targeting of these cells may contribute to increased risk of TB in early HIV-1 infection, before generalized T cell depletion.

  88. 88.

    et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J. Exp. Med. 207, 1609–1616 (2010).

  89. 89.

    & Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med. 208, 2251–2262 (2011).

  90. 90.

    et al. Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection. Mucosal Immunol. 10, 1069–1081 (2017).

  91. 91.

    et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 5, 670–680 (2012).

  92. 92.

    et al. Functional role of mucosal-associated invariant T cells in HIV infection. J. Leukoc. Biol. 100, 305–314 (2016).

  93. 93.

    et al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis. Am. J. Respir. Crit. Care Med. 190, 329–339 (2014).

  94. 94.

    , , , & Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS ONE 7, e34156 (2012).

  95. 95.

    et al. Dynamic perturbations of the T-cell receptor repertoire in chronic HIV infection and following antiretroviral therapy. Front. Immunol. 6, 664 (2016). Comprehensive T cell receptor repertoire analysis by next-generation sequencing of samples of patients infected with HIV-1 showed incomplete reconstitution of the T cell repertoire three months after effective ART.

  96. 96.

    et al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood 121, 951–961 (2013).

  97. 97.

    et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 505, 218–222 (2014).

  98. 98.

    & TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 153, 521–534 (2013).

  99. 99.

    , , & Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl Acad. Sci. USA 104, 6031–6036 (2007).

  100. 100.

    et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753–766 (2004).

  101. 101.

    et al. Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood 115, 4226–4236 (2010). This study shows inhibition of macrophage phagocytic uptake by the effect of the HIV-1 accessory protein Nef on AP1-mediated recycling of endosomes required for phagosome formation.

  102. 102.

    , , , & Short communication: circulating plasma HIV-1 viral protein R in dual HIV-1/tuberculosis infection. AIDS Res. Hum. Retroviruses 30, 644–647 (2014).

  103. 103.

    , , & Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett. 393, 93–96 (1996).

  104. 104.

    et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186, 255–268 (2009). Induction of autophagosome formation in HIV-1-infected macrophages, wherein HIV-1 Nef mediated autophagosome maturation, supports HIV-1 replication but counteracts autophagic degradation of the virus and might be expected to inhibit autophagic clearance of mycobacteria.

  105. 105.

    , & Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. Infect. Immun. 78, 4022–4032 (2010).

  106. 106.

    & Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 8, e1002689 (2012).

  107. 107.

    et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc. Natl Acad. Sci. USA 108, 19013–19017 (2011).

  108. 108.

    et al. HIV impairs TNF-α mediated macrophage apoptotic response to Mycobacterium tuberculosis. J. Immunol. 179, 6973–6980 (2007).

  109. 109.

    , , , & Impaired M. tuberculosis-mediated apoptosis in alveolar macrophages from HIV+ persons: potential role of IL-10 and BCL-3. J. Leukoc. Biol. 86, 53–60 (2009).

  110. 110.

    , , , & Exogenous Nef is an inhibitor of Mycobacterium tuberculosis-induced tumor necrosis factor-alpha production and macrophage apoptosis. J. Biol. Chem. 285, 12629–12637 (2010).

  111. 111.

    et al. Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. eLife 6, e22028 (2017).

  112. 112.

    et al. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am. J. Respir. Crit. Care Med. 185, 989–997 (2012).

  113. 113.

    et al. The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts. Clin. Infect. Dis. 58, 765–774 (2014).

  114. 114.

    , , , & Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int. J. Infect. Dis. 32, 39–45 (2015).

  115. 115.

    et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 251–261 (2010).

  116. 116.

    et al. HIV–tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nat. Commun. 6, 8451 (2015). Pro-inflammatory responses in patients with TB-IRIS were enriched for innate immune MYD88-mediated and inflammasome-mediated pathways in myeloid cells, suggesting that unregulated recovery of these pathways after ART is responsible for the pathogenesis of IRIS.

  117. 117.

    et al. MyD88-dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons. Blood 115, 3606–3615 (2010).

  118. 118.

    , , , & Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro. J. Biol. Chem. 283, 33191–33198 (2008).

  119. 119.

    , & HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect. Dis. 6, 794–804 (2006).

  120. 120.

    et al. Genome-wide innate immune responses in HIV-1-infected macrophages are preserved despite attenuation of the NF-kappa B activation pathway. J. Immunol. 182, 319–328 (2009).

  121. 121.

    et al. HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10. J. Infect. Dis. 209, 1055–1065 (2014). HIV-1-infected macrophages exhibit selective depletion of IL-10 responses to M. tuberculosis co-infection, leading to a failure of immunoregulation, exaggerated pro-inflammatory responses and increased HIV-1 replication.

  122. 122.

    et al. Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis. Tuberculosis 89, 285–293 (2009).

  123. 123.

    et al. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 25, 1455–1460 (2011).

  124. 124.

    et al. Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 27, 1725–1734 (2013).

  125. 125.

    et al. Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J. Acquir. Immune Def. Syndr. 28, 1–8 (2001).

  126. 126.

    , & HIV-1 transcription and latency: an update. Retrovirology 10, 67 (2013).

  127. 127.

    , , & Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Invest. 95, 2324–2331 (1995).

  128. 128.

    , & C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69, 5337–5344 (1995).

  129. 129.

    , , & Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the Toll-like receptor pathway. PLoS Pathog. 8, e1002620 (2012).

  130. 130.

    et al. Type I interferon induces inhibitory 16-kD CCAAT/ Enhancer Binding Protein (C/EBP)β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J. Exp. Med. 188, 1255–1265 (1998).

  131. 131.

    , , , & ESX secretion systems: mycobacterial evolution to counter host immunity. Nat. Rev. Microbiol. 14, 677–691 (2016).

  132. 132.

    & Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology 352, 485–492 (2006).

  133. 133.

    , , , & Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J. Virol. 68, 6967–6975 (1994).

  134. 134.

    et al. Interleukin-10 induces inhibitory C/EBPβ through STAT-3 and represses HIV-1 transcription in macrophages. Am. J. Respir. Cell. Mol. Biol. 33, 406–411 (2005).

  135. 135.

    , , , & Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl Acad. Sci. USA 86, 5974–5978 (1989).

  136. 136.

    , & Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl Acad. Sci. USA 91, 108–112 (1994).

  137. 137.

    et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172, 151–158 (1990).

  138. 138.

    , , , & Synergistic stimulatory effects of tumour necrosis factor α and interferon γ on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur. J. Clin. Invest. 26, 286–292 (1996).

  139. 139.

    et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284–1288 (2011).

  140. 140.

    , , & MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 326, 867–871 (2009).

  141. 141.

    et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012).

  142. 142.

    et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792–804 (2013).

  143. 143.

    et al. DNA damage signaling instructs polyploid macrophage fate in granulomas. Cell 167, 1264–1280.e18 (2016).

  144. 144.

    , & Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited Settings. Clin. Chest Med. 30, 685–699 (2009).

  145. 145.

    & A step forward understanding HIV-1 diversity. Retrovirology 13, 27 (2016).

  146. 146.

    et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–2012, with whole pathogen genome sequences: an observational study. Lancet Respir. Med. 2, 285–292 (2014).

  147. 147.

    et al. HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet. 9, e1003318 (2013).

  148. 148.

    et al. The influence of HIV on the evolution of Mycobacterium tuberculosis. Mol. Biol. Evol. 34, 1654–1668 (2017).

  149. 149.

    et al. TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines. Tuberculosis 99 (Suppl. 1), S8–S11 (2016).

Download references

Acknowledgements

L.C.K.B. was funded by a Medical Research Council Doctoral Training Award through the University College London MB PhD programme. M.N. is supported by a Wellcome Trust Investigator Award and National Institute of Health Research Biomedical Research Centre Funding to University College Hospitals National Health Service (NHS) Foundation Trust and University College London.

Author information

Affiliations

  1. Division of Infection & Immunity, Cruciform Building, University College London, WC1E 6BT, London, UK.

    • Lucy C. K. Bell
    •  & Mahdad Noursadeghi

Authors

  1. Search for Lucy C. K. Bell in:

  2. Search for Mahdad Noursadeghi in:

Contributions

L.C.K.B. and M.N. contributed to researching data for article. L.C.K.B. and M.N. substantially contributed to the discussion of content. L.C.K.B. and M.N. wrote the article. L.C.K.B. and M.N. reviewed and edited the manuscript before submission.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Mahdad Noursadeghi.

Glossary

Acid-fast bacillus

A bacterium that is resistant to decolourization during laboratory staining procedures, which is a recognized property of mycobacteria. This arises due to the high mycolic acid content of the bacterial cell wall. Several diagnostic tests for tuberculosis rely on this property, including Ziehl–Neelsen staining.

Independent risk factor

A variable that improves the prediction of outcome in a statistical model that already includes other variables.

Lung apices

The upper lobe of each lung.

Pleural effusions

Accumulations of fluid in the pleural cavity, the anatomical compartment that surrounds the lungs. This can arise due to a range of causes, one of which is infections such as tuberculosis.

Extra-pulmonary

Anatomical locations beyond the thoracic cavity or lung.

Mycobacteraemia

Circulation of mycobacteria in the bloodstream, identified by culture of blood.

Quasispecies

A genetically heterogenous population arising from a process of mutation and selection.

Viral rebound

Development of a detectable plasma viral load in an individual with HIV-1 following a period of virological suppression, typically associated with an interruption in antiretroviral therapy or the development of drug resistance.

Sentinel cells

Tissue-resident cells that initiate a host immune response.

T helper17 cells

CD4+ T helper cell subset that produces interleukin-17 (IL-17) on stimulation, which in turn has a canonical role in augmenting neutrophil responses to infection.

Resting T cells

T cells that have not been activated by binding of their cognate antigen to the T cell receptor or stimulation by mitogens.

Inflammasome

Multimeric molecular complexes formed during innate immune signalling that activate caspase enzymes, control maturation of the pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18 and may lead to cell death via pyroptosis.

Pyroptosis

A specific cell death pathway triggered by activation of caspase 1.

Immune senescence

The observable decline in immune function associated with ageing.

Immunoregulation

Mechanisms by which the immune system self-regulates via negative feedback loops, for example, the production of immunosuppressive cytokines.

Phagosome

A cytoplasmic vesicle formed as a result of the cellular uptake of particles >0.75 μm in diameter.

Granulomatous pathology

Chronic inflammatory foci within tissues, primarily made up of a core of activated macrophages surrounded by CD4+ T cells.

Efferocytosis

The process by which dead or dying cells are cleared by phagocytosis.

Pulmonary cavitation

Formation of large airspaces in the lung parenchyma due to tissue destruction.

Pro-inflammatory cytokines

Extracellular signalling molecules secreted chiefly by immune cells, which induce cell-surface receptors to trigger inflammatory processes.

Immunodominant

The antigenic epitopes most commonly targeted by the adaptive immune response.

Tuberculin skin test

(TST). Intradermal injection of a standardized preparation of a purified protein derivative of killed and homogenized Mycobacterium tuberculosis.

Necrotic granulomas

Granulomatous inflammation sites with a core of dead cells.

Bacillary load

The measurable quantity of bacteria within a host organism or sample.

Long terminal repeat

(LTR). Repetitive non-coding sequences at each end of the HIV-1 proviral DNA, which are formed during reverse transcription and have important roles in integration and regulation of viral gene expression.

Giant cells

Multinucleated cells derived from macrophages, typically found within granulomatous inflammation.

Sympatric speciation

The evolutionary process by which one species adapts to another with which it overlaps geographically.